[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652594":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":40,"responsibleParty":55,"collaborators":18,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":18,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":18,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":80,"whyStopped":18,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Holy Family Hospital, Nazareth, Israel","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"TENS Group","EXPERIMENTAL","Patient will receive TENS within 2 hours after surgery in addition to the standard analgesic protocol.",[13],"Device: TENS",{"label":15,"type":16,"description":17,"interventionNames":18},"No-TENS Control Group","NO_INTERVENTION","Patients will receive the standard analgesic protocol only.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DEVICE","TENS","Participants randomized to the intervention group will receive continuous transcutaneous electrical nerve stimulation (TENS) in addition to standard postoperative analgesia. TENS will be initiated within 2 hours after cesarean delivery and applied continuously for the first 24 postoperative hours. Participants will be instructed to wear the device continuously and may temporarily remove the device for showering. All participants will receive in addition the institution's standard postoperative care and analgesic regimen following cesarean delivery.",[9],[26],{"name":27,"affiliation":28,"role":29},"Raed Salim","The Azrieli Faculty of Medicine, Bar Ilan University","STUDY_CHAIR",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Maysa Abboud, MD","CONTACT","972-509516904","abboudmaysa@gmail.com",{"name":37,"role":33,"phone":38,"phoneExt":18,"email":39},"Raed Salim, MD","0544986960","r.salim@hfhosp.org",[41],{"facility":42,"status":18,"city":43,"state":18,"zip":18,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Holy Family Hospital","Nazareth","Israel","IL",{"type":47,"coordinates":48},"Point",[49,50],35.29719,32.70087,{"lat":50,"lon":49},[53],{"name":54,"role":33,"phone":18,"phoneExt":18,"email":39},"Raed",{"type":56,"investigatorFullName":37,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Professor","100652594","tens-use-for-post-cesarean-pain-management-100652594",false,"NCT07777939","TENS Use for Post-cesarean Pain Management","Continuous 24-Hour Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Management: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Women aged 18-45 years.\n* Undergoing CD under spinal anesthesia.\n* Hemodynamically stable postoperatively.\n* Able to provide informed consent.\n\nExclusion Criteria:\n\n* Undergoing CD under epidural or general anesthesia.\n* Skin lesions or infection at electrode placement sites.\n* Pacemaker or implanted electrical devices.\n* Neurological disorders affecting pain perception.\n* Chronic opioid use or chronic pain disorders.\n* Allergy or other contraindication to opioids, nonsteroidal antiinflammatory drugs, or acetaminophen use.\n* Adhesive allergy.\n* Midline vertical skin incision (in the current or previous cesarean).\n* Intraoperative sterilization.\n* Cesarean hysterectomy.","FEMALE","18 Years","45 Years",{"count":69,"type":70},196,"ESTIMATED","INTERVENTIONAL",[73],"NA","The aim of this randomized controlled trial is to evaluate the effectiveness of continuous 24-hour Transcutaneous Electrical Nerve Stimulation (TENS) as an adjunct to standard postoperative care for pain management following cesarean delivery. Eligible women undergoing cesarean delivery under spinal anesthesia will be randomly assigned in a 1:1 ratio to either the intervention group, which will receive continuous TENS in addition to standard postoperative analgesia, or the control group, which will receive standard postoperative analgesia alone. The primary outcome is the Quality of Recovery-15 (QoR-15) score assessed 24 hours after cesarean delivery.",[76],"Post Cesarean Pain Management",[78,22,79],"Cesarean delivery","POSTPARTUM PAIN","NOT_YET_RECRUITING","2026-08-18",{"date":83,"type":84},"2026-08-20","ACTUAL",{"date":86,"type":70},"2026-08",{"date":88,"type":70},"2027-09",{"name":5,"class":6},1]